HomeSMNR • OTCMKTS
add
Semnur Pharmaceuticals Inc
Previous close
$8.00
Year range
$4.50 - $23.00
Market cap
1.84B USD
Avg Volume
44.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.16M | 693.56% |
Net income | -6.16M | -693.56% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.00K | 66.67% |
Total assets | 1.35M | -79.86% |
Total liabilities | 22.10M | -55.33% |
Total equity | -20.75M | — |
Shares outstanding | 230.21M | — |
Price to book | -88.89 | — |
Return on assets | -1,452.36% | — |
Return on capital | 305.30% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -6.16M | -693.56% |
Cash from operations | -3.60M | -156.22% |
Cash from investing | — | — |
Cash from financing | 3.54M | 151.78% |
Net change in cash | -65.00K | -6,400.00% |
Free cash flow | -1.30M | — |
About
Founded
2013
Headquarters
Website
Employees
3
